Insider Sell: Jason Clemens Sells 35,000 Shares of AdaptHealth Corp (AHCO)

Author's Avatar
Dec 13, 2024
Article's Main Image

On December 10, 2024, Jason Clemens, the Chief Financial Officer of AdaptHealth Corp (AHCO, Financial), executed a sale of 35,000 shares of the company, as reported in a SEC Filing. Following this transaction, the insider now holds 420,719 shares of the company. AdaptHealth Corp (AHCO) is a leading provider of home healthcare equipment, medical supplies, and related services in the United States. The company focuses on providing a comprehensive suite of products and services to patients in their homes, including respiratory therapy, mobility products, and other medical equipment.

1867360182942724096.png

The insider transaction history for AdaptHealth Corp indicates that there have been no insider purchases over the past year, while there have been six insider sales during the same period. This recent sale by Jason Clemens is part of this trend, with the insider having sold a total of 35,000 shares in the past year without any purchases.

1867360199791243264.png

On the day of the sale, shares of AdaptHealth Corp were trading at $9.35 each, giving the stock a market cap of $1.25 billion. The stock's GF Value is estimated at $13.59, resulting in a price-to-GF-Value ratio of 0.69. This suggests that the stock is considered a "Possible Value Trap, Think Twice" based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated using three key factors: - Historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow that the stock has traded at. - A GuruFocus adjustment factor based on the company’s past returns and growth. - Future estimates of business performance from Morningstar analysts. This insider sale by Jason Clemens is a notable event for investors to consider when evaluating the stock's current valuation and future prospects.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.